BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alam MM, Jarvis CM, Hincapie R, McKay CS, Schimer J, Sanhueza CA, Xu K, Diehl RC, Finn MG, Kiessling LL. Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune Responses. ACS Nano 2021;15:309-21. [PMID: 32790346 DOI: 10.1021/acsnano.0c03023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Feng R, Zhu L, Heng X, Chen G, Chen H. Immune Effect Regulated by the Chain Length: Interaction between Immune Cell Surface Receptors and Synthetic Glycopolymers. ACS Appl Mater Interfaces 2021;13:36859-67. [PMID: 34333963 DOI: 10.1021/acsami.1c08785] [Reference Citation Analysis]
2 Rinoldi C, Zargarian SS, Nakielski P, Li X, Liguori A, Petronella F, Presutti D, Wang Q, Costantini M, De Sio L, Gualandi C, Ding B, Pierini F. Nanotechnology-Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID-19 Vaccines. Small Methods 2021;:2100402. [PMID: 34514087 DOI: 10.1002/smtd.202100402] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
3 Long Q, Yang Y, Yang M, Bai H, Sun W, Yang X, Huang W, Li D, Ma Y. Recombinant VLPs empower RBM peptides showing no immunogenicity in native SARS-COV-2 protein to elicit a robust neutralizing antibody response. Nanomedicine 2022;41:102527. [PMID: 35104670 DOI: 10.1016/j.nano.2022.102527] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Perciani CT, Liu LY, Wood L, MacParland SA. Enhancing Immunity with Nanomedicine: Employing Nanoparticles to Harness the Immune System. ACS Nano 2021;15:7-20. [PMID: 33346646 DOI: 10.1021/acsnano.0c08913] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
5 Toraskar S, Madhukar Chaudhary P, Kikkeri R. The Shape of Nanostructures Encodes Immunomodulation of Carbohydrate Antigen and Vaccine Development. ACS Chem Biol 2022;17:1122-30. [PMID: 35426652 DOI: 10.1021/acschembio.1c00998] [Reference Citation Analysis]
6 Wu S, Xia Y, Hu Y, Ma G. Bio-mimic particles for the enhanced vaccinations: Lessons learnt from the natural traits and pathogenic invasion. Adv Drug Deliv Rev 2021;176:113871. [PMID: 34311014 DOI: 10.1016/j.addr.2021.113871] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Li J, Chen S, Li Y, Zhu Z, Huang H, Wang W, Yang Y, Liang Y, Shu L. Comprehensive Profiling Analysis of CD209 in Malignancies Reveals the Therapeutic Implication for Tumor Patients Infected With SARS-CoV-2. Front Genet 2022;13:883234. [DOI: 10.3389/fgene.2022.883234] [Reference Citation Analysis]
8 McFall-Boegeman H, Huang X. Mechanisms of cellular and humoral immunity through the lens of VLP-based vaccines. Expert Rev Vaccines 2022. [PMID: 35023430 DOI: 10.1080/14760584.2022.2029415] [Reference Citation Analysis]
9 Stefanetti G, Borriello F, Richichi B, Zanoni I, Lay L. Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases. Front Cell Infect Microbiol 2022;11:808005. [DOI: 10.3389/fcimb.2021.808005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hartweg M, Jiang Y, Yilmaz G, Jarvis CM, Nguyen HV, Primo GA, Monaco A, Beyer VP, Chen KK, Mohapatra S, Axelrod S, Gómez-Bombarelli R, Kiessling LL, Becer CR, Johnson JA. Synthetic Glycomacromolecules of Defined Valency, Absolute Configuration, and Topology Distinguish between Human Lectins. JACS Au 2021;1:1621-30. [PMID: 34723265 DOI: 10.1021/jacsau.1c00255] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Anderluh M, Berti F, Bzducha-Wróbel A, Chiodo F, Colombo C, Compostella F, Durlik K, Ferhati X, Holmdahl R, Jovanovic D, Kaca W, Lay L, Marinovic-Cincovic M, Marradi M, Ozil M, Polito L, Reina-Martin JJ, Reis CA, Sackstein R, Silipo A, Švajger U, Vaněk O, Yamamoto F, Richichi B, van Vliet SJ. Emerging glyco-based strategies to steer immune responses. FEBS J 2021;288:4746-72. [PMID: 33752265 DOI: 10.1111/febs.15830] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Cai L, Du X, Zhang C, Yu S, Liu L, Zhao J, Zhao Y, Zhang C, Wu J, Wang B, Chen Y, Su X, Yan X, Li W. Robust immune response stimulated by in situ injection of CpG/αOX40/cGAMP in αPD-1-resistant malignancy. Cancer Immunol Immunother 2021. [PMID: 34731284 DOI: 10.1007/s00262-021-03095-z] [Reference Citation Analysis]
13 Lima GM, Atrazhev A, Sarkar S, Sojitra M, Reddy R, Torres-Obreque K, de Oliveira Rangel-Yagui C, Macauley MS, Monteiro G, Derda R. DNA-Encoded Multivalent Display of Chemically Modified Protein Tetramers on Phage: Synthesis and in Vivo Applications. ACS Chem Biol 2021. [PMID: 34928124 DOI: 10.1021/acschembio.1c00835] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ghosh C, Priegue P, Leelayuwapan H, Fuchsberger FF, Rademacher C, Seeberger PH. Synthetic Glyconanoparticles Modulate Innate Immunity but Not the Complement System. ACS Appl Bio Mater . [DOI: 10.1021/acsabm.2c00026] [Reference Citation Analysis]